Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Stuttgart - Delayed Quote • EUR GSK PLC (GS71.SG) Follow Add holdings 17.38 +0.58 +(3.48%) At close: April 30 at 9:31:13 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for GS71.SG 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: GS71.SG View More All News Press Releases SEC Filings GSK Jumps On Solid Earnings, Says It's 'Well Positioned' To Navigate Tariffs GSK (LSE:GSK) Sees First Quarter Sales of £7.5 Billion and Net Income Surge Trending tickers: Super Micro, Starbucks, Snap, GSK and Aston Martin GSK Sales, Profit Rise on Boost from HIV, Cancer Drugs GSK 'well positioned' for potential tariffs after beating forecasts Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca Shingles Vaccine Appears to Lower Dementia Risk Why vaccine makers aren't worried about Trump administration cuts Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices